Literature DB >> 17199855

Clinical presentation of epithelioid angiomyolipoma.

Hang Kyu Park1, Shaozeng Zhang, Michael K K Wong, Hyung L Kim.   

Abstract

OBJECTIVE: Epithelioid angiomyolipomas (AML) of the kidney are malignant tumors with aggressive clinical behavior.
METHODS: We reviewed cases of epithelioid AML recently diagnosed at our institution to highlight the spectrum of clinical presentations.
RESULTS: In all cases, renal lesions seen on computed tomography were suspicious for renal cell carcinoma (RCC). Histologically, these tumors can resemble RCC. The diagnosis of epithelioid AML was established by positive staining for melanoma and smooth muscle cell markers, and presence of perivascular epithelioid cells. One patient presented with a renal tumor extending into the inferior vena cava to the level of the hepatic veins. Two patients developed recurrent, metastatic disease following nephrectomy. One patient with tuberous sclerosis and multiple, bilateral AML developed an enhancing renal tumor that did not contain any fat densities. A partial nephrectomy was performed and pathology revealed epithelioid AML adjacent to conventional AML.
CONCLUSIONS: These tumors are distinguished from RCC by positive immunostaining for melanoma markers and smooth muscle cell markers. They resemble conventional RCC on imaging. Epithelioid AML may be locally aggressive and metastasize.

Entities:  

Mesh:

Year:  2007        PMID: 17199855     DOI: 10.1111/j.1442-2042.2006.01665.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  21 in total

1.  An unusually large renal angiomyolipoma peeping into the right atrium.

Authors:  Thotton Veedu Prasad; Anuradha Singh; Chandan J Das; Amlesh Seth
Journal:  BMJ Case Rep       Date:  2016-06-27

2.  Clinical presentation, management, and outcome of patients with incidental renal angiomyolipoma in qatar.

Authors:  Hassan Al-Thani; Ayman El-Menyar; Maryam Al-Sulaiti; Jamela El-Mabrok; Khairi Hajaji; Hesham Elgohary; Ahmed Al-Malki; Abdelhakem Tabeb
Journal:  Oman Med J       Date:  2014-11

3.  Renal epithelioid angiomyolipoma: MRI findings.

Authors:  Yan Zhong; Yanguang Shen; Jingjing Pan; Yingwei Wang; Yunxia An; Aitao Guo; Lu Ma; Huiyi Ye; Haiyi Wang
Journal:  Radiol Med       Date:  2017-07-10       Impact factor: 3.469

Review 4.  Primary hepatic epithelioid angiomyolipoma: A malignant potential tumor which should be recognized.

Authors:  Jie Liu; Cheng-Wu Zhang; De-Fei Hong; Ran Tao; Yuan Chen; Min-Jie Shang; Yu-Hua Zhang
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  Resection of a staggering 36-cm angiomyolipoma.

Authors:  Bishoy A Gayed; Bruce L Jacobs; Erin P Gibbons; Ronald L Hrebinko
Journal:  Can Urol Assoc J       Date:  2010-08       Impact factor: 1.862

6.  Partial nephrectomy can be a successful treatment option for renal epithelioid angiomyolipoma: a case report and literature review.

Authors:  Aurelija Liulytė; Algirdas Žalimas; Raimundas Meškauskas; Jurgita Ušinskienė; Feliksas Jankevičius
Journal:  Acta Med Litu       Date:  2020

7.  Clinically relevant imaging in tuberous sclerosis.

Authors:  Rupa Radhakrishnan; Sadhna Verma
Journal:  J Clin Imaging Sci       Date:  2011-07-27

Review 8.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

9.  Angiomyolipoma with epithelial cysts (AMLEC): a rare but distinct variant of angiomyolipoma.

Authors:  Henry B Armah; Ming Yin; Uma N M Rao; Anil V Parwani
Journal:  Diagn Pathol       Date:  2007-03-21       Impact factor: 2.644

Review 10.  A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review.

Authors:  Jun H Lei; Liang R Liu; Qiang Wei; Tu R Song; Lu Yang; Hai C Yuan; Yong Jiang; Huan Xu; Sheng H Xiong; Ping Han
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.